PAK3 and lung carcinoma: Consistent with our experimental findings, bioinformatics analysis of a published human cancer dataset (between seven metastatic samples from lung cancers and 123 primary site lung tumor samples)35 demonstrated an overall reduction in SMAD4 expression and an elevation of PAK3 expression displaying a strong negative correlation (Supplementary Fig. 9c, d and Data 9).